首页 产品目录 分子砌块 按反应类型 烷基化 甲基((S)-1-((S)-2-(5-(7-(4-(2-((S)-1-((甲氧羰基)-L-缬氨酰)吡咯烷-2-基)-1H-咪唑-5-基)苯基)苯并[d][1,3]二氧杂环戊烯-4-基)-1H-咪唑-2-基)吡咯烷-1-基)-3-甲基-1-氧代丁-2-基)氨基甲酸酯二盐酸盐

甲基((S)-1-((S)-2-(5-(7-(4-(2-((S)-1-((甲氧羰基)-L-缬氨酰)吡咯烷-2-基)-1H-咪唑-5-基)苯基)苯并[d][1,3]二氧杂环戊烯-4-基)-1H-咪唑-2-基)吡咯烷-1-基)-3-甲基-1-氧代丁-2-基)氨基甲酸酯二盐酸盐

Methyl ((S)-1-((S)-2-(5-(7-(4-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)phenyl)benzo[d][1,3]dioxol-4-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate dihydrochloride

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量
1mg 98% 询价
- +
5mg 98% 询价
- +
10mg 98% 询价
- +
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

1966138-53-3

中文名称

甲基((S)-1-((S)-2-(5-(7-(4-(2-((S)-1-((甲氧羰基)-L-缬氨酰)吡咯烷-2-基)-1H-咪唑-5-基)苯基)苯并[d][1,3]二氧杂环戊烯-4-基)-1H-咪唑-2-基)吡咯烷-1-基)-3-甲基-1-氧代丁-2-基)氨基甲酸酯二盐酸盐

英文名称

Methyl ((S)-1-((S)-2-(5-(7-(4-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)phenyl)benzo[d][1,3]dioxol-4-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate dihydrochloride

别名

Carbamic acid, N-[(1S)-1-[[(2S)-2-[5-[4-[7-[2-[(2S)-1-[(2S)-2-[(methoxycarbonyl)amino]-3-methyl-1-oxobutyl]-2-pyrrolidinyl]-1H-imidazol-5-yl]-1,3-benzodioxol-4-yl]phenyl]-1H-imidazol-2-yl]-1-pyrrolidinyl]carbonyl]-2-methylpropyl]-, methyl ester, hydrochloride (1:2);Coblopasvir dihydrochloride;Coblopasvir dihydrochloride(1312608-46-0 Free base);HCV Protease,inhibit,Coblopasvir dihydrochloride,KW136,Coblopasvir,HCV,chronic hepatitis C virus infection,pangenotypic regimen,Hepatitis C virus,KW-136,NS5A,KW 136,Inhibitor;Coblopasvir dihydrochloride, 10 mM in DMSO

标准英文名

methyl ((S)-1-((S)-2-(5-(7-(4-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)phenyl)benzo[d][1,3]dioxol-4-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate dihydrochloride

分子式

C41H52Cl2N8O8

分子量

855.82

精确分子量

854.33

SMILES

O=C(OC)N[C@@H](C(C)C)C(N1[C@H](C2=NC=C(C3=C4OCOC4=C(C5=CC=C(C6=CN=C([C@H]7N(C([C@H](C(C)C)NC(OC)=O)=O)CCC7)N6)C=C5)C=C3)N2)CCC1)=O.[H]Cl.[H]Cl

标准SMILES

Cl.Cl.CC(C)[C@H](NC(=O)OC)C(=O)N1CCC[C@H]1C1NC(=CN=1)C1C=CC(=CC=1)C1C=CC(=C2OCOC=12)C1=CN=C(N1)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)OC)C(C)C

用途

Coblopasvir dihydrochloride is a pangenotypic HCV NS5A inhibitor developed by Beijing Kawin Technology Co., Ltd., used for the treatment of chronic hepatitis C virus (HCV) infection; it exhibits nanomolar-level antiviral activity against HCV replicons, demonstrating high potency against multiple HCV genotypes; approved by China's National Medical Products Administration (NMPA) in February 2020 in combination with sofosbuvir for the treatment of HCV.

InChIKey

NQXPKJCTLPFQIS-KJIUXTSNSA-N

安全信息

SureRoute逆合成路线

1.  1966138-53-3 逆合成路线 1

—
—
—
—
ACYYHQ882
1966138-53-3
来源: SureRoute

2.  1966138-53-3 逆合成路线 2

—
—
—
—
ACYYHQ882
1966138-53-3
来源: SureRoute

3.  1966138-53-3 逆合成路线 3

—
—
—
—
ACYYHQ882
1966138-53-3
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手